Overview
Vaping technology firm's fiscal Q2 revenue declined, missing analyst expectations
Net loss for fiscal Q2 narrowed compared to the previous year
Company reduced operating expenses due to cost-cutting measures
Outlook
Ispire plans to increase production in Malaysia throughout fiscal 2026
Company sees potential licensing opportunities for G-Mesh technology
Ispire collaborates with regulators to support age-gating technology adoption
Result Drivers
CUSTOMER SHIFT - Revenue decreased due to strategic shift away from lower quality cannabis customers, impacting overall product sales
ACCOUNTS RECEIVABLE REDUCTION - Co reduced net accounts receivable by 19.5% to $37.9 mln, enhancing financial flexibility
MANUFACTURING EXPANSION - Co ramping up manufacturing capabilities in Malaysia to increase production
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $20.30 mln | $32.80 mln (1 Analyst) |
Q2 EPS | -$0.12 | ||
Q2 Net Income | -$6.60 mln | ||
Q2 Gross Margin | 17.10% | ||
Q2 Gross Profit | $3.50 mln | ||
Q2 Operating Expenses | $10.30 mln |
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the tobacco peer group is "buy"
Wall Street's median 12-month price target for Ispire Technology Inc is $6.50, about 112.4% above its February 5 closing price of $3.06
Press Release: ID:nPn83JJSma
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)